Aspira Women's Health, Inc. (AWH)
| Market Cap | 360.86M |
| Revenue (ttm) | 5.98M |
| Net Income (ttm) | -23.36M |
| Shares Out | 111.96M |
| EPS (ttm) | -0.22 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 117,056 |
| Open | 3.21 |
| Previous Close | 3.23 |
| Day's Range | 3.17 - 3.28 |
| 52-Week Range | 2.98 - 10.54 |
| Beta | 3.05 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings Date | Nov 11, 2021 |
About AWH
Aspira Women's Health Inc., together with its subsidiaries, discovers, develops, and commercializes diagnostic and bio-analytical solutions that help physicians to diagnose, treat, and enhance gynecologic health outcomes for women in the United States. It provides OVA1, Overa, and Ova1PLUS to detect the risk of ovarian malignancy. The company also offers ASPiRA GenetiX, a genetic test for the risk of gynecologic cancer. In addition, it owns and operates ASPiRA LABS, a lab that specializes in applying biomarker-based technologies to address crit...
Financial Performance
In 2020, AWH's revenue was $4.65 million, an increase of 2.49% compared to the previous year's $4.54 million. Losses were -$17.91 million, 17.5% more than in 2019.
Financial StatementsNews
Aspira Women's Health Executes Four Aspira SynergyTM Technology Transfer Agreements
Aspira Women's Health has entered into partnership agreements with two of the largest U.S.-based women's health networks and two independent U.S. laboratories. Aspira Women's Health has entered into par...
Aspira Women's Health Inc. to Present at the Cantor Fitzgerald Virtual Global Healthcare Conference
AUSTIN, Texas, Sept. 21, 2021 (GLOBE NEWSWIRE) -- Aspira Women's Health, Inc. (Nasdaq: AWH), a bioanalytical-based women's health company, today announced that it will present at the Cantor Fitzgerald V...
Aspira Women's Health Kicks Off Ovarian Cancer Awareness Month by Further Establishing Itself as a Thought Leader in ...
Signals Call to Action for Immediate Progress in Conquering Ovarian Cancer Signals Call to Action for Immediate Progress in Conquering Ovarian Cancer
Aspira (AWH) Reports Q2 Loss, Tops Revenue Estimates
Aspira (AWH) delivered earnings and revenue surprises of 0.00% and 5.82%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Aspira Women's Health Reports Second Quarter 2021 Financial Results
Total Revenue Increased 141% to $1.8 million; OVA1 Volume Grew 85% to 4,553 Accessions
Analysts Estimate Aspira (AWH) to Report a Decline in Earnings: What to Look Out for
Aspira (AWH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Aspira Women's Health Inc. to Report Second Quarter 2021 Financial Results on August 12
AUSTIN, Texas, July 27, 2021 (GLOBE NEWSWIRE) -- Aspira Women's Health, Inc. (Nasdaq: AWH), a bioanalytical-based women's health company, today announced that it will report financial results for the se...
Aspira Women's Health (AWH) is Oversold: Can It Recover?
Aspira Women's Health (AWH) has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock.
UPDATE -- Aspira Women's Health Inc. Announces Coverage for OVA1® in the AIM Specialty Health Laboratory Medicine Cli...
AUSTIN, Texas, July 08, 2021 (GLOBE NEWSWIRE) -- Aspira Women's Health Inc. (Nasdaq: AWH) today announced its OVA1® risk assessment test for ovarian cancer in women with pelvic masses is considered medi...
Aspira Women's Health Inc. to Participate in the William Blair Growth Stock Conference
AUSTIN, Texas, May 19, 2021 (GLOBE NEWSWIRE) -- Aspira Women's Health, Inc. (Nasdaq: AWH), a bioanalytical-based women's health company, today announced that management will participate in and present a...
Aspira (AWH) Reports Q1 Loss, Tops Revenue Estimates
Aspira (AWH) delivered earnings and revenue surprises of 79.17% and 6.86%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Aspira Women's Health Reports First Quarter 2021 Financial Results
Conference call scheduled for today, May13 at 4:30 p.m. ET Conference call scheduled for today, May13 at 4:30 p.m. ET
Aspira Women's Health, Inc. Expands Leadership Team with Industry Veteran
New Team Addition Is a Thought Leader in Reimbursement and Diagnostics New Team Addition Is a Thought Leader in Reimbursement and Diagnostics
Earnings Preview: Aspira (AWH) Q1 Earnings Expected to Decline
Aspira (AWH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
What Traders Can Expect From Small Caps in 2021
Below is a repost of an article from Benzina.com, which features Schaeffer's V.P.
Aspira (AWH) Reports Q4 Loss, Tops Revenue Estimates
Aspira (AWH) delivered earnings and revenue surprises of -1350.00% and 11.23%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Aspira Women's Health Reports Fourth Quarter and Full Year 2020 Financial Results
Conference Call scheduled for today, March 25th at 4:30 p.m. ET Conference Call scheduled for today, March 25th at 4:30 p.m. ET
Aspira Women's Health, Inc. Announces an Agreement for the Development and Commercialization of an Early-Detection Te...
AUSTIN, Texas, March 25, 2021 (GLOBE NEWSWIRE) -- Aspira Women's Health, Inc. (Nasdaq: AWH), a bioanalytical-based women's health company, today announced it has entered into an agreement with Dana-Farb...
Analysts Estimate Aspira (AWH) to Report a Decline in Earnings: What to Look Out for
Aspira (AWH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Aspira Women's Health Inc. Appoints Nicole Sandford to its Board of Directors
AUSTIN, Texas, Feb. 22, 2021 (GLOBE NEWSWIRE) -- Aspira Women's Health Inc. (Nasdaq: AWH), a bioanalytical-based women's health company, today announced the appointment of Ms. Nicole Sandford to its Boa...
Aspira Women's Health, Inc. to Participate in BTIG's Virtual MedTech, Digital Health, Life Science and Diagnostic Too...
AUSTIN, Texas, Feb. 12, 2021 (GLOBE NEWSWIRE) -- Aspira Women's Health, Inc. (Nasdaq: AWH), a bioanalytical-based women's health company, today announced management will participate and present in the 2...
Aspira Women's Health, Inc. to add NCCN Management Recommendations to its Proprietary Aspira GenetiX™ Clinical Report
Aspira will incorporate Management Recommendations from the National Comprehensive Cancer Network® (NCCN®) Clinical Practice Guidelines in Oncology (NCCN Guidelines®) in the Aspira GenetiX report Aspira...
Aspira Women's Health Inc. Announces Pricing of $45 Million Public Offering of Common Stock
AUSTIN, Texas, Feb. 04, 2021 (GLOBE NEWSWIRE) -- Aspira Women's Health Inc. (Nasdaq: AWH) (“Aspira”), a bio-analytical based women's health company focused on gynecologic disease, today announced the pr...
Aspira Women's Health Inc. Announces Proposed Public Offering of Common Stock
AUSTIN, Texas, Feb. 03, 2021 (GLOBE NEWSWIRE) -- Aspira Women's Health Inc. (Nasdaq: AWH) (“Aspira”), a bio-analytical based women's health company focused on gynecologic disease, today announced it has...
These Were the 5 Best Diagnostics Stocks of 2020
These winners are positioned for gains even after COVID.